1. Home
  2. NGNE vs PCB Comparison

NGNE vs PCB Comparison

Compare NGNE & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$18.30

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$21.42

Market Cap

307.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGNE
PCB
Founded
2003
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
327.8M
307.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NGNE
PCB
Price
$18.30
$21.42
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
$40.14
$24.50
AVG Volume (30 Days)
152.7K
19.5K
Earning Date
11-13-2025
01-27-2026
Dividend Yield
N/A
3.71%
EPS Growth
N/A
43.50
EPS
N/A
2.41
Revenue
N/A
$107,743,000.00
Revenue This Year
N/A
$21.55
Revenue Next Year
N/A
$8.65
P/E Ratio
N/A
$8.94
Revenue Growth
N/A
13.61
52 Week Low
$6.88
$16.00
52 Week High
$37.27
$24.04

Technical Indicators

Market Signals
Indicator
NGNE
PCB
Relative Strength Index (RSI) 45.81 43.77
Support Level $18.12 $21.42
Resistance Level $20.44 $22.64
Average True Range (ATR) 1.23 0.61
MACD 0.23 -0.05
Stochastic Oscillator 48.61 5.86

Price Performance

Historical Comparison
NGNE
PCB

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

Share on Social Networks: